Mid-cap cannabis producers Aleafia Health
Ontario-based Aleafia has secured Health Canada authorization to increase the licensed outdoor cultivation area from 292,000 sq. ft. to more than 1.1 million sq. ft at its Port Perry facility. It will begin planting in the newly licensed area today and the cannabis grown there will be extracted and turned into various concentrates at its nearby Paris facility.
“The immediate four-fold increase in Aleafia Health’s licensed and operational cultivation area is our most significant milestone to date,” said Aleafia Health Chairman Julian Fantino.
Chief executive Geoffrey Benic added that the firm’s increased scale will drive efficiency savings and allow it to produce cannabis products at a lower overall cost.
Flowr has received a Health Canada license for a facility called Forest Flowr, which should yield 10,000 kg of cannabis flower per year. That will double the overall capacity at the firm’s Kelowna campus in British Columbia.
It expects to complete its first harvest in Q4 2019 and that will be in time for the Canadian market opening up for edibles, vapes, and other concentrates. Flowr said the first new product launch from Flowr Forest to be a live resin vape brand.
It believes it has the team, the technology and the raw materials to produce a high quality with richly aromatic terpene profiles and a great taste.
Toronto-based Flowr also spoke about making efficiency savings by having outdoor cultivation and indoor greenhouse areas on the same campus. Flowr is firmly focused on the ultra-premium end of the Canadian cannabis market, but it recently acquired Australian firm Holigen, which is building one of the world’s largest facilities in Portugal’s Alentejo region.
It expects to produce more than 600,000 kg per year in Portugal, while Flowr will continue creating high-quality cannabis in much smaller batches in Canada.
Aleafia has a bigger footprint in Canada after completing the purchase of Emblem earlier this year. Its domestic capacity is expected to be around 150,000 kg as it expands and builds out its facilities.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.